Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement 2022-07-05 15:00
Endurance RP Limited (SEHK:0575.HK) Operational Update on the PE Prevention Drug Fortacin™ / Senstend™ 2022-07-05 12:06
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities 2022-07-05 09:20
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia 2022-07-04 22:14
JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma 2022-07-04 19:30
Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders 2022-07-04 18:00
Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061 2022-07-04 13:34
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection 2022-07-04 08:10
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis 2022-07-04 08:00
Brii Biosciences Exercises Option for Vir Biotechnology's VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China 2022-07-04 07:10
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer 2022-07-01 22:00
GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia 2022-07-01 09:16
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover 2022-06-30 20:43
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover 2022-06-30 20:16
Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK 2022-06-30 12:41
Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918 2022-06-30 10:41
Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan 2022-06-30 08:00
Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China 2022-06-29 20:14
BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures 2022-06-29 20:00
Positive data from the clinical phase I MAD study with AlzeCure's Alzheimer's project NeuroRestore ACD856 2022-06-29 19:32
1 128 129 130 131 132 377